GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » SCWorx Corp (NAS:WORX) » Definitions » Cash-to-Debt

SCWorx (SCWorx) Cash-to-Debt : 0.72 (As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is SCWorx Cash-to-Debt?

Cash to Debt Ratio measures the financial strength of a company. It is calculated as a company's cash, cash equivalents, and marketable securities divide by its debt. SCWorx's cash to debt ratio for the quarter that ended in Sep. 2023 was 0.72.

If Cash to Debt ratio is less than 1, the company cannot pay off its debt using the cash in hand. Here we can see, SCWorx couldn't pay off its debt using the cash in hand for the quarter that ended in Sep. 2023.

The historical rank and industry rank for SCWorx's Cash-to-Debt or its related term are showing as below:

WORX' s Cash-to-Debt Range Over the Past 10 Years
Min: 0   Med: 1.22   Max: No Debt
Current: 0.72

During the past 8 years, SCWorx's highest Cash to Debt Ratio was No Debt. The lowest was 0.00. And the median was 1.22.

WORX's Cash-to-Debt is ranked worse than
50.38% of 655 companies
in the Healthcare Providers & Services industry
Industry Median: 0.74 vs WORX: 0.72

SCWorx Cash-to-Debt Historical Data

The historical data trend for SCWorx's Cash-to-Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: An indication of "No Debt" does not necessarily mean that the company has no debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

SCWorx Cash-to-Debt Chart

SCWorx Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cash-to-Debt
Get a 7-Day Free Trial 0.02 No Debt 1.28 0.16 1.68

SCWorx Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cash-to-Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.35 1.68 1.94 1.17 0.72

Competitive Comparison of SCWorx's Cash-to-Debt

For the Health Information Services subindustry, SCWorx's Cash-to-Debt, along with its competitors' market caps and Cash-to-Debt data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SCWorx's Cash-to-Debt Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, SCWorx's Cash-to-Debt distribution charts can be found below:

* The bar in red indicates where SCWorx's Cash-to-Debt falls into.



SCWorx Cash-to-Debt Calculation

This is the ratio of a company's Cash, Cash Equivalents, Marketable Securities to its debt. The debt includes the Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation. This ratio measures the financial strength of a company. This ratio is updated quarterly.

SCWorx's Cash to Debt Ratio for the fiscal year that ended in Dec. 2022 is calculated as:

SCWorx's Cash to Debt Ratio for the quarter that ended in Sep. 2023 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SCWorx  (NAS:WORX) Cash-to-Debt Explanation

If Cash to Debt ratio is greater than 1, the company can pay off its debt using the cash in hand. If it is smaller than 1, it means the company has more debt than the cash in hands. In this case, it is important to look the the company's Interest Coverage. Ben Graham requires that a company must have an Interest Coverage of at least 5.


SCWorx Cash-to-Debt Related Terms

Thank you for viewing the detailed overview of SCWorx's Cash-to-Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


SCWorx (SCWorx) Business Description

Traded in Other Exchanges
Address
590 Madison Avenue, 21st Floor, New York, NY, USA, 10022
SCWorx Corp is a provider of data content and services related to the repair, normalization, and interoperability of information for healthcare providers, as well as big data analytics for the healthcare industry. Its software enables a healthcare provider to simplify and organize its data, allows the data to be utilized across multiple internal software applications and provides the basis for sophisticated data analytics.
Executives
Vincent Michael Matozzo director 412 RICHARD LANE, ORANGE CT 06477
Christopher John Kohler officer: Chief Financial Officer 1149 CANTERBERRY LN, PARKER CO 80138
Steven Wallitt director C/O SCWORX CORP., 590 MADISON AVENUE, 21ST FLOOR, NEW YORK NY 10022
John C Ferrara director C/O EDGAR ONLINE, INC., 50 WASHINGTON STREET, NORWALK CT 06854
Steven Ross Horowitz director 4 MELISSA COURT, MONTVILLE NJ 07045
Marc Sanford Schessel director, 10 percent owner, officer: CEO 4 JACOBS LANE, NEW PALTZ NY 12561
Irby Alton F Iii director C/O MCKESSON CORP, ONE POST ST., SAN FRANCISCO CA 94104
Miller Charles Kenneth Iii director 100 METROPLEX, EDISON NJ 08817
Timothy Andrew Hannibal officer: President, COO 590 MADISON AVE, NEW YORK NY 10022
Mark Shefts director 160 SUMMIT AVE, MONTVALE NJ 07645
John C Price other: Former CFO 4721 IRONTON STREET, BUILDING A, DENVER CO 80239
Robert Steven Christie director 34 SAN MARCO STREET, WEST WINDSOR NJ 08550
Ira E. Ritter director C/O RITTER PHARMACEUTICALS INC., 1801 CENTURY PARK EAST, SUITE 1820, LOS ANGELES CA 90096
Knuettel Ii Francis director 205 NEWBURY ST, SUITE 204, FRAMINGHAM MA 01701
James Thaddeus Schweikert officer: Chief Operating Officer 7783 SOARING EAGLE CT., CINCINNATI OH 45244